Risperidone hydrochloride

CAS No. 666179-74-4

Risperidone hydrochloride ( Apexidone;R-64766;R64766 )

Catalog No. M15541 CAS No. 666179-74-4

An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1229 Get Quote
50MG 2507 Get Quote
100MG 3168 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Risperidone hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.
  • Description
    An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties; also has actions at several 5-HT receptor subtypes, adrenergic receptors and histamine H1 receptors.Schizophrenia Approved
  • Synonyms
    Apexidone;R-64766;R64766
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    Neurological Disease
  • Indication
    Schizophrenia

Chemical Information

  • CAS Number
    666179-74-4
  • Formula Weight
    446.95
  • Molecular Formula
    C23H28ClFN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F.Cl
  • Chemical Name
    4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-, hydrochloride (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Janssen PA, et al. J Pharmacol Exp Ther. 1988 Feb;244(2):685-93.
2. Megens AA, et al. Psychopharmacology (Berl). 1988;95(4):493-6.
3. Dugovic C, et al. Neuropharmacology. 1989 Dec;28(12):1431-3.
4. Smith C, et al. Mol Pharmacol. 2006 Oct;70(4):1264-70.
molnova catalog
related products
  • PF-05212377

    PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.

  • Mirtazapine

    Mirtazapine is an antidepressant introduced by Organon International in 1996 used for the treatment of moderate to severe depression.

  • AVN-322

    A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia.